CLRB icon

Cellectar Biosciences

12 hedge funds and large institutions have $3.01M invested in Cellectar Biosciences in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$108K
2 +$21K
3 +$10.2K
4
Victory Capital Management
Victory Capital Management
Texas
+$3K

Top Sellers

1 -$887K
2 -$231K
3 -$22K
4
Morgan Stanley
Morgan Stanley
New York
-$5.98K
5
AIC
AWM Investment Company
New York
-$5K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.84M
2
$471K
3
$354K
4
$175K
5
$64K
6
$34K
7
$21K
8
$20K
9
$18K
10
$6K
11
$3K
12
$54
13
14
15
16